Andrew Goodall

No más puestos en curso

Fortuna: 1 M $ al 30/04/2024

58 años

Health Technology

Perfil

Andrew Ernest Goodall served as a Non-Executive Director at Memphasys Ltd.
from 2012 to 2023.
He also held the same position at PrIME Biologics Pte Ltd.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
MEMPHASYS LTD 13.17%	29/11/2023	180 149 529 ( 13.17% )	1 M $	30/04/2024

Antiguos cargos conocidos de Andrew Goodall.

Empresas	Cargo	Fin
MEMPHASYS	Director/Miembro de la Junta	30/11/2023
PrIME Biologics Pte Ltd. PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Andrew Goodall.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andrew Goodall.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
MEMPHASYS	Health Technology

Empresas privadas	1
PrIME Biologics Pte Ltd. PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore.	Health Technology